Systemic lupus erythematosus and associated organ damage in real-world settings: estimating damage scores using administrative claims data
Our findings suggest that real-world administrative claims data can effectively estimate damage scores in patients with SLE, and that the increase in scores correlates with a higher economic burden.
Authors
- Michael Schultze (ORCID: https://orcid.org/0009-0002-1494-5446)
- M Pignot
- Heike Carnarius (ORCID: https://orcid.org/0000-0001-7317-8270)
- RA Levy
- Kerry Gairy
- Elena Garal-Pantaler
- Matthias Schneider
Institutions
- Düsseldorf University Hospital (DE)
- GlaxoSmithKline (United States) (US)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Behörde für Gesundheit und Verbraucherschutz (DE)
- GlaxoSmithKline (Germany) (DE)
- DAK-Gesundheit (Germany) (DE)
- Berlin Center for Epidemiology and Health Research (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.55563/clinexprheumatol/oj01ky
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00